title: Orbital lymphoma masquerading as panuveitis.
abstract: OBJECTIVE
  To describe a case of orbital mucosa-associated lymphoid tissue (MALT) lymphoma masquerading as unilateral panuveitis.
  
  
  METHODS
  Retrospective chart review.
  
  
  RESULTS
  A 53-year-old female patient with unilateral vitritis and exudative retinal detachment refractory to immunosuppressive treatment was eventually diagnosed with orbital MALT lymphoma. Following treatment with radiotherapy and rituximab, the patient's intraocular inflammation and retinal detachment resolved.
  
  
  CONCLUSIONS
  Orbital MALT lymphoma can masquerade as refractory unilateral panuveitis with exudative retinal detachment and appears to respond to a combination of radiotherapy and specific B-cell-targeted systemic therapy.
authors.affiliation: National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Puneet
authors.initials: P
authors.lastname: Panda
authors.forename: Farzin
authors.initials: F
authors.lastname: Forooghian
authors.forename: Todd
authors.initials: T
authors.lastname: Goodglick
authors.forename: Chi-Chao
authors.initials: CC
authors.lastname: Chan
authors.forename: Robert
authors.initials: R
authors.lastname: Nussenblatt
authors.forename: H Nida
authors.initials: HN
authors.lastname: Sen
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D008875:Middle Aged; D009918:Orbital Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D015864:Panuveitis / Q000175:diagnosis* / Q000209:etiology; D018714:Radiotherapy, Adjuvant; D000069283:Rituximab; D041623:Tomography, Optical Coherence; D014057:Tomography, X-Ray Computed
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab